 | | COMPOUND: C07312 | |
| Entry |
|
|---|
| Name |
Stavudine;
d4T;
2',3'-Didehydro-3'-deoxythimidine;
Sanilvudine
|
|---|
| Formula |
C10H12N2O4
|
|---|
| Exact mass |
224.0797
|
|---|
| Mol weight |
224.2133
|
|---|
| Structure |
|
|---|
| Remark |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
J05AF04 Stavudine
D00445 Stavudine (USAN/INN)
USP drug classification [BR:br08302]
Antivirals
Anti-HIV Agents, Nucleoside and Nucleotide Reverse Transcriptase Inhibitors (NRTI)
Stavudine
D00445 Stavudine (USAN/INN)
Drug groups [BR:br08330]
Antiviral
DG01890 Nucleoside reverse transcriptase inhibitor (NRTI)
D00445 Stavudine
DG03107 Anti-HIV agent
DG01656 HIV reverse transcriptase inhibitor
D00445 Stavudine
Drug classes [BR:br08332]
Antiviral
DG03107 Anti-HIV agent
D00445 Stavudine
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D00445 Stavudine (USAN/INN)
Antimicrobials abbreviations [BR:br08327]
Antivirals
Genome replication inhibitor
HIV reverse transcriptase inhibitor
D00445 Stavudine (USAN/INN)
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00445
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 16
1 C1y C 24.2900 -18.8300
2 N4y N 25.6200 -17.9200
3 O2x O 23.1700 -17.9900
4 C2x C 23.8000 -20.0900
5 C8y C 26.8800 -17.2200
6 C8x C 24.4300 -17.2200
7 C1y C 22.0500 -18.7600
8 C2x C 22.4700 -20.0900
9 N4x N 26.8800 -15.8200
10 O5x O 28.0700 -17.9200
11 C8y C 24.4300 -15.8200
12 C1b C 20.7200 -18.3400
13 C8y C 25.6900 -15.1200
14 C1a C 23.3100 -15.0500
15 O1a O 19.6700 -19.2500
16 O5x O 25.6900 -13.7900
BOND 17
1 1 2 1 #Up
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 4 8 2
8 5 9 1
9 5 10 2
10 6 11 2
11 7 12 1 #Up
12 9 13 1
13 11 14 1
14 12 15 1
15 13 16 2
16 7 8 1
17 11 13 1
|
|---|
|
» Japanese version
|
|